11/3
11:03 am
edsa
Edesa Biotech (NASDAQ:EDSA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
Edesa Biotech (NASDAQ:EDSA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.